What is the recommended rectal dose of Cytolog (misoprostol) tablets for an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Rectal Misoprostol Dosing for Adults

For adults requiring rectal misoprostol administration, the recommended dose is 800-1000 mcg (0.8-1.0 g) rectally, which can be repeated every 6 hours as needed, with a maximum of 50 g per day. 1

Standard Rectal Dosing Protocol

  • Initial dose: 1 g/kg up to 50 g rectally every 6 hours as needed 1
  • This dosing is derived from established guidelines for rectal administration of medications requiring gastrointestinal absorption 1
  • The rectal route provides systemic absorption when oral administration is not feasible 1

Clinical Context and Route Selection

Misoprostol is primarily formulated as an oral tablet but can be administered via multiple routes including oral, vaginal, sublingual, buccal, and rectal 2, 3. The rectal route may be considered when:

  • Oral administration is contraindicated or not tolerated 2
  • Vaginal administration is inappropriate for the clinical indication 3
  • Patient preference or clinical circumstances favor rectal administration 3

Route-Specific Efficacy Considerations

The vaginal and sublingual routes demonstrate superior efficacy compared to oral administration for most obstetric indications 3. However, when rectal administration is specifically required:

  • Absorption may be more erratic compared to other routes 1
  • The rectal route has been successfully used for various prostaglandin applications 1
  • Bioavailability and time to peak effect differ from oral administration 2

Important Safety Considerations

Absolute contraindications must be observed regardless of route:

  • Never use in women with previous cesarean delivery or uterine scarring - the uterine rupture risk is 13%, which is catastrophically high and potentially fatal 4
  • Avoid in patients with active gastrointestinal bleeding or obstruction 5
  • Use with extreme caution in patients with cardiovascular disease due to potential hypotensive effects 6

Common Side Effects

Regardless of administration route, misoprostol commonly causes 2, 3:

  • Gastrointestinal symptoms (nausea, vomiting, diarrhea, abdominal cramping)
  • Shivering and fever
  • Headache
  • These effects are dose-dependent and may be more pronounced with higher doses 2

Monitoring Requirements

  • Observe for signs of excessive gastrointestinal effects 2
  • Monitor vital signs if used for obstetric indications 4
  • Watch for signs of hypersensitivity reactions 2

Related Questions

What birth control methods can be used after a misoprostol (prostaglandin E1 analogue) termination?
Can misoprostol be given as an oral solution for labor induction?
Can Cytotec (misoprostol) be used to facilitate cervical dilation for endometrial biopsies?
What are the guidelines for dispensing misoprostol (prostaglandin E1 analog)?
How should misoprostol be administered (dose, route, timing) to an adult woman before a colposcopy that requires cervical dilation for biopsy or loop electrosurgical excision?
In an adult with chronic obstructive pulmonary disease, is low‑dose aspirin (75–81 mg daily) appropriate for secondary cardiovascular prevention, and what contraindications (aspirin‑exacerbated respiratory disease, active gastrointestinal ulcer, high bleeding risk) must be considered?
What semaglutide (Ozempic) dose is equivalent to tirzepatide (Mounjaro) 7.5 mg weekly?
Why is tight glucose control crucial in gestational diabetes mellitus during pregnancy, and what are the recommended target levels and management strategies?
A patient on isosorbide mononitrate (ISMN) develops symptomatic bradycardia (heart rate <50 bpm with dizziness, syncope, or fatigue); what is the likely cause and how should it be managed?
Which intranasal corticosteroid is safest for most patients and what are the recommended dosing regimens for adults, adolescents, and children, including precautions for comorbid conditions?
Why is the tacrolimus trough level low in a patient eight years after kidney transplantation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.